TGN

TGN Biotech is a South Korean biotechnology company specializing in the production of high-value recombinant therapeutic proteins using transgenic animal bioreactor technology. The company focuses on developing cost-effective methods for manufacturing complex biologics, such as blood clotting factors and growth factors, by utilizing the mammary glands of transgenic cattle and pigs as living factories. Their pipeline primarily targets hematological disorders, including Hemophilia A and B, as well as various forms of anemia. By leveraging their proprietary expression systems, TGN Biotech aims to overcome the scalability and cost limitations associated with traditional cell-culture-based protein production.